Information Provided By:
Fly News Breaks for May 13, 2019
May 13, 2019 | 07:07 EDT
Barclays analyst Kristen Stewart upgraded Becton Dickinson to Overweight from Equal Weight with an unchanged price target of $266. The pullback in the shares since the FDA update on drug-coated balloons on March 15, coupled with the resetting of expectations following the company's Q2 results, provides an opportunity for investors, Stewart tells investors in a research note. The analyst believes the reaction to the FDA update is overdone and that the upcoming FDA Committee meeting on June 19-20 is likely to provide greater clarity and calm drug-coated balloons concerns.
News For BDX From the Last 2 Days
There are no results for your query BDX